Analyst Articles – Company Sum

Evofem Biosciences (EVFM) – Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Evofem Biosciences (NASDAQ: EVFM) in the last few weeks: 11/7/2018 – Evofem Biosciences was given a new $9.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a “buy” rating on the stock. 11/7/2018 – Evofem Biosciences was given a […]

Metro (B4B3) – Investment Analysts’ Weekly Ratings Changes

Metro (ETR: B4B3) recently received a number of ratings updates from brokerages and research firms: 11/12/2018 – Metro was given a new €15.00 ($17.44) price target on by analysts at Commerzbank AG. They now have a “neutral” rating on the stock. 11/8/2018 – Metro was given a new €14.40 ($16.74) price target on by analysts […]

Analysts’ Weekly Ratings Updates for Alphabet (GOOG)

Alphabet (NASDAQ: GOOG) recently received a number of ratings updates from brokerages and research firms: 11/6/2018 – Alphabet was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating. 11/2/2018 – Alphabet had its “neutral” rating reaffirmed by analysts at JMP Securities. 10/29/2018 – Alphabet had its “buy” rating reaffirmed by […]

Weekly Investment Analysts’ Ratings Changes for Interrent Real Estate Investment Trust (IIP.UN)

A number of research firms have changed their ratings and price targets for Interrent Real Estate Investment Trust (TSE: IIP.UN): 11/1/2018 – Interrent Real Estate Investment Trust had its price target raised by analysts at BMO Capital Markets from C$12.50 to C$13.50. 10/31/2018 – Interrent Real Estate Investment Trust had its price target raised by […]

Recent Investment Analysts’ Ratings Updates for Diplomat Pharmacy (DPLO)

Diplomat Pharmacy (NYSE: DPLO) recently received a number of ratings updates from brokerages and research firms: 11/13/2018 – Diplomat Pharmacy was upgraded by analysts at Zacks Investment Research from a “strong sell” rating to a “hold” rating. According to Zacks, “Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids […]

Investment Analysts’ Recent Ratings Changes for DWS Group & GmbH Co KgaA (DWS)

DWS Group & GmbH Co KgaA (ETR: DWS) recently received a number of ratings updates from brokerages and research firms: 10/31/2018 – DWS Group & GmbH Co KgaA was given a new €25.00 ($29.07) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock. 10/26/2018 – […]

Weekly Research Analysts’ Ratings Changes for Calithera Biosciences (CALA)

A number of firms have modified their ratings and price targets on shares of Calithera Biosciences (NASDAQ: CALA) recently: 11/12/2018 – Calithera Biosciences was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering […]

Adverum Biotechnologies (ADVM) – Investment Analysts’ Recent Ratings Changes

Adverum Biotechnologies (NASDAQ: ADVM) recently received a number of ratings updates from brokerages and research firms: 11/4/2018 – Adverum Biotechnologies was downgraded by analysts at Cantor Fitzgerald from an “overweight” rating to a “hold” rating. They now have a $4.00 price target on the stock, down previously from $12.00. They wrote, “. We are downgrading […]

Seres Therapeutics (MCRB) – Investment Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Seres Therapeutics (NASDAQ: MCRB) in the last few weeks: 11/10/2018 – Seres Therapeutics was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 11/9/2018 – Seres Therapeutics was given a new $16.00 price target on by analysts at Oppenheimer […]

Barclays (BARC) – Research Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of Barclays (LON: BARC) recently: 11/9/2018 – Barclays was given a new GBX 210 ($2.74) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock. 11/2/2018 – Barclays was given a new GBX […]

Investment Analysts’ Weekly Ratings Changes for PulteGroup (PHM)

PulteGroup (NYSE: PHM) recently received a number of ratings updates from brokerages and research firms: 11/12/2018 – PulteGroup was downgraded by analysts at Bank of America Corp from a “neutral” rating to an “underperform” rating. They now have a $26.00 price target on the stock. 10/25/2018 – PulteGroup was upgraded by analysts at Evercore ISI […]

GrafTech International (EAF) – Research Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for GrafTech International (NYSE: EAF): 11/12/2018 – GrafTech International was downgraded by analysts at Vertical Group from a “buy” rating to a “sell” rating. 11/6/2018 – GrafTech International had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $24.00. They […]

Analysts’ Weekly Ratings Changes for Dorian LPG (LPG)

Dorian LPG (NYSE: LPG) has recently received a number of price target changes and ratings updates: 11/7/2018 – Dorian LPG was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Dorian LPG Ltd is a liquefied petroleum gas shipping company. It is primarily focused on owning […]

Analysts’ Weekly Ratings Updates for Zendesk (ZEN)

A number of firms have modified their ratings and price targets on shares of Zendesk (NYSE: ZEN) recently: 11/3/2018 – Zendesk was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Zendesk, Inc. is a software development company. It provides a software-as-a-service, or SaaS, customer service […]

Recent Research Analysts’ Ratings Changes for CymaBay Therapeutics (CBAY)

A number of research firms have changed their ratings and price targets for CymaBay Therapeutics (NASDAQ: CBAY): 11/7/2018 – CymaBay Therapeutics was given a new $18.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a “buy” rating on the stock. 11/7/2018 – CymaBay Therapeutics was given a new $17.00 price target […]

Analysts’ Recent Ratings Updates for International Consolidated Airlns Grp (IAG)

International Consolidated Airlns Grp (LON: IAG) has recently received a number of price target changes and ratings updates: 11/6/2018 – International Consolidated Airlns Grp was given a new GBX 780 ($10.19) price target on by analysts at Credit Suisse Group AG. They now have a “buy” rating on the stock. 11/5/2018 – International Consolidated Airlns […]

Weekly Investment Analysts’ Ratings Updates for Opus Bank (OPB)

A number of firms have modified their ratings and price targets on shares of Opus Bank (NASDAQ: OPB) recently: 11/8/2018 – Opus Bank was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 10/29/2018 – Opus Bank was downgraded by analysts at TheStreet from a “b-” rating to a “c” rating. […]

Moelis & Co (MC) – Investment Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Moelis & Co (NYSE: MC) recently: 11/6/2018 – Moelis & Co is now covered by analysts at Goldman Sachs Group Inc. They set a “buy” rating and a $53.00 price target on the stock. 10/25/2018 – Moelis & Co was downgraded […]

Galmed Pharmaceuticals (GLMD) – Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Galmed Pharmaceuticals (NASDAQ: GLMD) recently: 11/8/2018 – Galmed Pharmaceuticals was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $12.00 price target on the stock. According to Zacks, “Galmed Pharmaceuticals Ltd. […]

Recent Investment Analysts’ Ratings Changes for Achaogen (AKAO)

Several analysts have recently updated their ratings and price targets for Achaogen (NASDAQ: AKAO): 11/12/2018 – Achaogen had its “neutral” rating reaffirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock, down previously from $19.00. They wrote, “916-3963, POS Risk-adj value Full value Rating ZEMDRI – U.S. 100% $1.92 […]

BNP Paribas (BNP) – Research Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of BNP Paribas (EPA: BNP) in the last few weeks: 11/6/2018 – BNP Paribas was given a new €71.70 ($83.37) price target on by analysts at Jefferies Financial Group Inc. They now have a “buy” rating on the stock. 11/1/2018 – BNP Paribas was […]

Analysts’ Recent Ratings Changes for Cypress Semiconductor (CY)

Several analysts have recently updated their ratings and price targets for Cypress Semiconductor (NASDAQ: CY): 11/1/2018 – Cypress Semiconductor was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating. 10/26/2018 – Cypress Semiconductor was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating. 10/26/2018 – Cypress […]

Research Analysts’ Weekly Ratings Updates for Inogen (INGN)

Inogen (NASDAQ: INGN) has recently received a number of price target changes and ratings updates: 11/7/2018 – Inogen was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating. 11/7/2018 – Inogen had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $280.00 price target on […]

IGM Financial (IGM) – Research Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for IGM Financial (TSE: IGM): 11/5/2018 – IGM Financial had its price target raised by analysts at BMO Capital Markets from C$38.00 to C$39.00. They now have an “outperform” rating on the stock. 11/5/2018 – IGM Financial had its price target raised by […]

Recent Analysts’ Ratings Changes for Genocea Biosciences (GNCA)

Several brokerages have updated their recommendations and price targets on shares of Genocea Biosciences (NASDAQ: GNCA) in the last few weeks: 11/8/2018 – Genocea Biosciences was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Genocea Biosciences, Inc. is involved in developing vaccines. The company’s proprietary […]

Analysts’ Recent Ratings Changes for Viavi Solutions (VIAV)

Viavi Solutions (NASDAQ: VIAV) recently received a number of ratings updates from brokerages and research firms: 11/7/2018 – Viavi Solutions was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating. 11/2/2018 – Viavi Solutions had its price target raised by analysts at JPMorgan Chase & Co. from $11.00 to $12.00. They […]

Analysts’ Weekly Ratings Updates for Horizon Global (HZN)

A number of firms have modified their ratings and price targets on shares of Horizon Global (NYSE: HZN) recently: 11/10/2018 – Horizon Global was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong sell” rating. According to Zacks, “Horizon Global Corporation is a designer, manufacturer and distributor of towing, trailering, […]

Investment Analysts’ Recent Ratings Updates for Aimmune Therapeutics (AIMT)

A number of firms have modified their ratings and price targets on shares of Aimmune Therapeutics (NASDAQ: AIMT) recently: 11/12/2018 – Aimmune Therapeutics was given a new $62.00 price target on by analysts at Cantor Fitzgerald. They now have a “buy” rating on the stock. 11/11/2018 – Aimmune Therapeutics was given a new $33.00 price […]

Investment Analysts’ Recent Ratings Changes for GEA Group Aktiengesellschaft (G1A)

A number of firms have modified their ratings and price targets on shares of GEA Group Aktiengesellschaft (ETR: G1A) recently: 11/12/2018 – GEA Group Aktiengesellschaft was given a new €29.00 ($33.72) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock. 11/7/2018 – GEA Group Aktiengesellschaft was […]

Analysts’ Recent Ratings Updates for Elastic (ESTC)

Several brokerages have updated their recommendations and price targets on shares of Elastic (NYSE: ESTC) in the last few weeks: 10/30/2018 – Elastic is now covered by analysts at Barclays PLC. They set an “overweight” rating and a $79.00 price target on the stock. 10/30/2018 – Elastic is now covered by analysts at Royal Bank […]

Analysts’ Recent Ratings Changes for Biogen (BIIB)

Several brokerages have updated their recommendations and price targets on shares of Biogen (NASDAQ: BIIB) in the last few weeks: 11/6/2018 – Biogen was upgraded by analysts at ValuEngine from a “sell” rating to a “hold” rating. 11/6/2018 – Biogen was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 10/28/2018 […]

Weekly Research Analysts’ Ratings Changes for Canadian Tire (CTC.A)

Several analysts have recently updated their ratings and price targets for Canadian Tire (TSE: CTC.A): 11/9/2018 – Canadian Tire had its price target raised by analysts at National Bank Financial from C$179.00 to C$181.00. They now have an “outperform” rating on the stock. 11/9/2018 – Canadian Tire had its price target raised by analysts at […]

Weekly Analysts’ Ratings Changes for Covestro (1COV)

Several analysts have recently updated their ratings and price targets for Covestro (ETR: 1COV): 11/8/2018 – Covestro had its “neutral” rating reaffirmed by analysts at DZ Bank AG. 11/5/2018 – Covestro had its “sell” rating reaffirmed by analysts at Goldman Sachs Group Inc. 11/5/2018 – Covestro was given a new €66.00 ($76.74) price target on […]

Recent Analysts’ Ratings Updates for Golden Entertainment (GDEN)

Golden Entertainment (NASDAQ: GDEN) has recently received a number of price target changes and ratings updates: 11/12/2018 – Golden Entertainment had its price target lowered by analysts at Telsey Advisory Group from $36.00 to $24.00. They now have an “outperform” rating on the stock. 11/10/2018 – Golden Entertainment was given a new $38.00 price target […]

Recent Analysts’ Ratings Changes for Gilead Sciences (GILD)

Gilead Sciences (NASDAQ: GILD) has recently received a number of price target changes and ratings updates: 11/8/2018 – Gilead Sciences was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 11/1/2018 – Gilead Sciences had its “buy” rating reaffirmed by analysts at Raymond James. 11/1/2018 – Gilead Sciences was given a […]

Kindred Biosciences (KIN) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Kindred Biosciences (NASDAQ: KIN): 11/8/2018 – Kindred Biosciences had its price target raised by analysts at B. Riley from $16.00 to $21.00. They now have a “buy” rating on the stock. 11/8/2018 – Kindred Biosciences was given a new $19.00 price target […]

Recent Research Analysts’ Ratings Changes for Honeywell International (HON)

A number of research firms have changed their ratings and price targets for Honeywell International (NYSE: HON): 10/30/2018 – Honeywell International had its price target lowered by analysts at Credit Suisse Group AG from $165.00 to $158.00. They now have a “neutral” rating on the stock. 10/30/2018 – Honeywell International was given a new $186.00 […]

Weekly Research Analysts’ Ratings Changes for Alibaba Group (BABA)

A number of firms have modified their ratings and price targets on shares of Alibaba Group (NYSE: BABA) recently: 11/5/2018 – Alibaba Group had its price target lowered by analysts at JPMorgan Chase & Co. to $190.00. They now have an “overweight” rating on the stock. 11/5/2018 – Alibaba Group was given a new $203.00 […]

Weekly Investment Analysts’ Ratings Updates for Alaska Air Group (ALK)

Alaska Air Group (NYSE: ALK) recently received a number of ratings updates from brokerages and research firms: 11/12/2018 – Alaska Air Group is now covered by analysts at Goldman Sachs Group Inc. They set a “buy” rating on the stock. 10/26/2018 – Alaska Air Group had its price target raised by analysts at Raymond James […]

Endurance International Group (EIGI) – Investment Analysts’ Weekly Ratings Changes

Endurance International Group (NASDAQ: EIGI) recently received a number of ratings updates from brokerages and research firms: 11/7/2018 – Endurance International Group was downgraded by analysts at Oppenheimer Holdings Inc. from an “outperform” rating to a “market perform” rating. 10/30/2018 – Endurance International Group was upgraded by analysts at Zacks Investment Research from a “hold” […]

Karyopharm Therapeutics (KPTI) – Investment Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Karyopharm Therapeutics (NASDAQ: KPTI) recently: 11/9/2018 – Karyopharm Therapeutics was upgraded by analysts at Wedbush from a “neutral” rating to an “outperform” rating. They now have a $19.00 price target on the stock. 11/8/2018 – Karyopharm Therapeutics was upgraded by analysts […]

Weekly Investment Analysts’ Ratings Updates for bluebird bio (BLUE)

A number of firms have modified their ratings and price targets on shares of bluebird bio (NASDAQ: BLUE) recently: 11/5/2018 – bluebird bio had its price target lowered by analysts at Wedbush from $204.00 to $166.00. They now have an “outperform” rating on the stock. 11/5/2018 – bluebird bio had its price target lowered by […]

Analysts’ Weekly Ratings Changes for Hikma Pharmaceuticals (HIK)

Several analysts have recently updated their ratings and price targets for Hikma Pharmaceuticals (LON: HIK): 11/9/2018 – Hikma Pharmaceuticals had its “equal weight” rating reaffirmed by analysts at Barclays PLC. They now have a GBX 1,950 ($25.48) price target on the stock. 11/8/2018 – Hikma Pharmaceuticals had its “add” rating reaffirmed by analysts at Peel […]

Recent Research Analysts’ Ratings Updates for Deutsche Post (DPW)

Several brokerages have updated their recommendations and price targets on shares of Deutsche Post (FRA: DPW) in the last few weeks: 11/7/2018 – Deutsche Post was given a new €34.50 ($40.12) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock. 11/7/2018 – Deutsche Post was […]

Analysts’ Weekly Ratings Updates for Hostess Brands (TWNK)

Several brokerages have updated their recommendations and price targets on shares of Hostess Brands (NASDAQ: TWNK) in the last few weeks: 11/8/2018 – Hostess Brands had its price target lowered by analysts at Royal Bank of Canada from $14.00 to $12.00. They now have a “sector perform” rating on the stock. 11/8/2018 – Hostess Brands […]

Research Analysts’ Recent Ratings Updates for Apptio (APTI)

Several analysts have recently updated their ratings and price targets for Apptio (NASDAQ: APTI): 11/2/2018 – Apptio was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $29.00 price target on the stock. According to Zacks, “Apptio, Inc. is a provider of cloud-based technology business […]

Recent Research Analysts’ Ratings Changes for ANI Pharmaceuticals (ANIP)

A number of research firms have changed their ratings and price targets for ANI Pharmaceuticals (NASDAQ: ANIP): 11/9/2018 – ANI Pharmaceuticals was given a new $70.00 price target on by analysts at Canaccord Genuity. They now have a “buy” rating on the stock. 11/6/2018 – ANI Pharmaceuticals was given a new $74.00 price target on […]

Weekly Research Analysts’ Ratings Updates for Mirati Therapeutics (MRTX)

Several analysts have recently updated their ratings and price targets for Mirati Therapeutics (NASDAQ: MRTX): 11/8/2018 – Mirati Therapeutics was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating. 11/6/2018 – Mirati Therapeutics had its “buy” rating reaffirmed by analysts at Cann. They now have a $57.00 price target on the […]

Control4 (CTRL) – Investment Analysts’ Recent Ratings Changes

Control4 (NASDAQ: CTRL) has recently received a number of price target changes and ratings updates: 11/7/2018 – Control4 had its “in-line” rating reaffirmed by analysts at Imperial Capital. They now have a $32.00 price target on the stock. 11/6/2018 – Control4 was given a new $24.00 price target on by analysts at Imperial Capital. They […]

Clarus (CLAR) – Analysts’ Recent Ratings Updates

Clarus (NASDAQ: CLAR) recently received a number of ratings updates from brokerages and research firms: 11/8/2018 – Clarus was upgraded by analysts at BidaskClub from a “buy” rating to a “strong-buy” rating. 10/31/2018 – Clarus was downgraded by analysts at BidaskClub from a “strong-buy” rating to a “buy” rating. 10/30/2018 – Clarus was upgraded by […]